deltatrials

University of Arizona Clinical Trials

Sponsors / University of Arizona

ClinicalTrials.gov lists 235 trials for which University of Arizona is named as lead sponsor. The portfolio currently includes 23 recruiting studies, 10 active non-recruiting studies, and 119 completed studies. 29 trials in this portfolio were terminated or withdrawn before completion. The most common reasons cited for termination include investigator or site changes, slow or insufficient recruitment. Cumulative planned enrollment across all listed trials is 46,147 participants. These counts reflect the current state of the public ClinicalTrials.gov registry.

235
Total Trials
23
Recruiting
10
Other Active
119
Completed
29
Terminated / Withdrawn
46,147
Total Enrollment

Termination reasons: Other45% · PI/or_Site21% · Recruitment17% · Regulatory7% · Funding7% · Safety3%

Recent Terminations

  • NCT03937765 Phase NA Stopped Mar 2024
    PRP
    "Suspended per IRB"
  • NCT05243914 Stopped Jan 2024
    Heart Transplantation
    "Slow study enrollment"
  • NCT05650086 Stopped Jun 2023
    Breast Cancer
    "PI has left the institution (University of Arizona Cancer Center)."
  • NCT05489445 Stopped Nov 2022
    Atrial Fibrillation
    "Sponsor closed the product line."
  • NCT04295720 Phase NA Stopped Mar 2022
    Chemo-brain
    "Stopped due to the risk of COVID-19 variants to our subject base of cancer patients"
  • NCT06661005 Phase EARLY_PHASE1 Stopped Sep 2021
    Nitrous Oxide
    "The study team didn't have the nitrous oxide to conduct the study."
  • NCT04088240 Phase NA Stopped Jan 2021
    Cardiovascular Risk Factor
    "Supplements Expired"
  • NCT04374786 Phase NA Stopped Dec 2020
    Anxiety
    "Loss to follow up. No longer enrolling."
  • NCT04001855 Phase NA Stopped May 2020
    Atopic Dermatitis
    "Investigator left university"
  • NCT04230291 Phase NA Stopped Mar 2020
    Hidradenitis Suppurativa
    "Principal investigator is not longer at this institution"

Active Trials (10 total)

Top Conditions

Top Locations